questions for the agm, page-37

I thing a lot of the sell-off was Ethical Fund offloading, but suspect it should bounce back strongly. Regardless, my overall feeling based on the above discussion and attending the meeting is very positive. The Quintile representative at the AGM, who had flown out from Europe (the UK?) was very optimistic and positive about the relationship with Tissue Therapis, and I think will be an ideal partner for us going forward. As SM said in the meeting when referring to other bio-tech's experience with large pharma deals, "if you are going to get in bed with an elephant you had better be careful when it rolls over".